These transgenic HSCs bearing the mutated TRIM5α would be implanted to achieve long-term cell repopulation in order to generate a durable subset of CD4+ T cells resistant to HIV-1 infection as reported with the CCR5 gene (Xu et al., 2017). Here, CCR5 is linked to HIV-1 infection.